Remed Co Ltd
KOSDAQ:302550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Remed Co Ltd
KOSDAQ:302550
|
KR |
|
Davide Campari Milano NV
F:58H1
|
IT |
|
H
|
Halliburton Co
XHAM:HAL
|
US |
|
Eenergy Group PLC
F:A1Z1
|
UK |
|
Grifols SA
F:G0F
|
ES |
|
S
|
Synopsys Inc
XMUN:SYP
|
US |
|
Aurelia Metals Ltd
ASX:AMI
|
AU |
|
O
|
Organigram Global Inc
F:0OG
|
CA |
|
DSV A/S
F:DS81
|
DK |
|
Advanced Info Service PCL
OTC:AVIFY
|
TH |
|
Matador Resources Co
NYSE:MTDR
|
US |
|
Hoshi Iryo-Sanki Co Ltd
TSE:7634
|
JP |
|
Codan Ltd
ASX:CDA
|
AU |
|
A
|
Alphabet Inc
DUS:ABEA
|
US |
|
Mitsubishi Corp
TSE:8058
|
JP |
|
D
|
Draganfly Inc
NASDAQ:DPRO
|
CA |
|
S
|
Sebitchem Co Ltd
KOSDAQ:107600
|
KR |
|
D
|
Digitalist Group Oyj
OMXH:DIGIGR
|
FI |
|
Bankinter SA
OTC:BKNIY
|
ES |
|
D
|
Deutsche Telekom AG
SWB:DTEA
|
DE |
|
D
|
Deutsche Telekom AG
XHAN:DTE
|
DE |
|
F
|
Fraser and Neave Ltd
OTC:FNEVF
|
SG |
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
Bankruptcy Probability
Remed Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Remed Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
R
|
Remed Co Ltd
KOSDAQ:302550
|
77.8B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
174.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
103.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
64.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
33B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Remed Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Remed Co Ltd has total debt of 3.3B KRW. This includes both short-term (590m KRW) and long-term (2.7B KRW) debt.
You can find a full breakdown on its Balance Sheet.